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ABSTRACT
Objective: This study aimed to evaluate the effect of the provision of drug-related information and patient education booklets on the hemoglobin A1c 
(HbA1c) levels of patients with type 2 diabetes mellitus.
Methods: This prospective study was conducted at the Kembangan Health Center, West Jakarta, Indonesia, from March to June 2017. A total of 
30 patients were divided into two equal groups: In addition to routine treatment, patients in the intervention group received drug-related information 
and patient education booklet, while those in the control group received no additional intervention. The provision of drug information was through 
direct education as well as through telephone, short messages, and booklet. HbA1c level was measured as a surrogate measure of treatment adherence. 
HbA1c concentration was measured at baseline and 11 weeks after the intervention.
Results: Mean HbA1c level in the intervention group decreased from 8.05±0.91% at week 0 to 6.92±0.47% at week 11 after intervention (p<0.05).
Conclusion: In this study, provision of drug information and patient education booklets helped to improve the patient compliance.
Keywords: Hemoglobin A1c, Patient adherence, Type 2 diabetes mellitus, Drug information, Booklet, Pharmacist.
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disorder characterized by high 
blood glucose levels caused by insufficient insulin. According to the 
International Diabetes Federation [1], the global prevalence of DM 
in 2014 was 8.3%, which corresponded to a caseload of 387 million 
patients. Globally, Indonesia has the seventh highest incidence of 
DM in the world after China, India, United States, Brazil, Russia, and 
Mexico. The estimated number of diabetic patients in Indonesia is 
8.5 million [1].
DM necessitates long-term treatment which is typically complex. 
The treatment cost increases by 2–3.5 times in patients who develop 
complications. Optimal treatment compliance helps prevent disease 
progression. Poor disease management and low adherence lead to 
poor drug efficacy [2]. Monitoring of hemoglobin A1c (HbA1c) levels 
every 3 months helps monitor glycemic control to ensure treatment 
efficacy. High level of HbA1c reflects poor diabetic control owing to low 
adherence to treatment [3].
Education of patients about the management of DM was shown to 
lower the HbA1c level by 0.3–0.76% [4,5]. The purpose of this study 
was to assess the impact of pharmacist-led provision of drug-related 
information and patient education on treatment adherence by patients 
to achieve successful therapy. Insights gained from this study may 
help to improve the quality of life of patients with type 2 DM during 
management treatment and help improve the role of pharmacists in 
health service sector in Indonesia.
METHODS
Study design and subjects
This prospective study was conducted at a Health Center in the 
Kembangan District of West Jakarta from March to June 2017. The 
study protocol was approved by the Ethical Committee for Health 
Study at the Faculty of Medicine of Universitas Indonesia before the 
start of the study. The study population comprised of 30 patients 
with type 2 DM who were prescribed oral antidiabetic drugs. Patients 
were divided into two groups: Intervention group received drug 
information and booklet, while the control group did not receive 
drug information and booklet. Each group consisted of 15 patients 
according to the total minimum sample [6]. The inclusion criteria 
were as follows: Patients aged >35 years who were diagnosed with 
type 2 DM at least 3 months before the start of the study. Patients 
who were receiving medicines such as birth control pills and herbal 
medicine and those on insulin therapy were excluded from the study. 
Patients in the intervention group received drug-related information 
at the time of dispensing of medicine by pharmacist as well as through 
phone call, short message service (SMS), and booklet. HbA1c levels 
were measured as a surrogate measure of patient adherence using 
Afinion™ AS100 Analyzer.
Materials used to collect data in this study were questionnaire and 
booklet [7]. The questionnaire consisted of a list of questions against 
which a respondent was required to indicate his response by means 
of a check (√) mark in the available column; a space for short answers 
was also available for each question. Booklet used in this study was 
prepared by Puspitasari [8] and modified by Yuniarti [9] for patients 
with type 2 DM in Depok. The information in the booklet was provided 
in a manner that was easy to understand by an average patient. 
Information in the booklet included the types of DM, normal blood 
glucose level, symptoms, complications, medications, management, 
signs of hypoglycemia, routine monitoring, prevention, and 
management of diabetic foot.
Samples collection
Sample collection method used in this study was consecutive sampling 
method. During data collection pre- and post-intervention, the sample 
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of capillary blood was collected from all subjects by finger prick to 
measure the HbA1c level. The flow chart for group allocation and 
attrition among the subjects is found in Fig. 1.
Statistical analysis
Univariate analysis was used for descriptive data. Between-group 
differences were assessed using t-test. Distribution of variables was 
assessed using Shapiro–Wilk, and the bivariate analysis was performed 
according to the data distribution result. p<0.05 were considered to be 
statistically significant difference. All analyses were performed on SPSS 
version 20 (IBM Corp., USA).
RESULTS
Study subject characteristic
Demographic and anthropometric characteristics of the patients are 
presented in Table 1, whereas clinical characteristics are presented in 
Table 2.
No significant difference was observed between the two groups with 
respect to the proportion of male and female patients. Basic Health 
Research results showed that the prevalence of DM among women 
is higher than that in men [10]. This is consistent with the study by 
Irawan [11] which showed that the higher prevalence of DM in women 
is attributable to a higher risk of increase in body mass index (BMI) 
due to premenstrual syndrome which leads to accumulation of body 
fat [12].
No significant between-group difference was observed with respect 
to the age of patients (p=0.713) [13]. The average BMI in the two 
groups also showed no significant difference (p=0.856) [14]. However, 
a significant difference was observed with respect to education level 
of patients between the two groups (p=0.048). Individuals with high 
education level tend to be more aware and health conscious. The 
result was similar with the study of Presetiawati [15] which found that 
education level affects patient’s adherence to medication. However, 
there was no significant between-group difference with respect to 
employment status.
No significant between-group difference was observed with respect to 
baseline FPG, 2-h PPG, systolic BP, diastolic BP, or duration of DM.
We also did not find a significant difference with respect to the number 
of oral antihyperglycemic drugs prescribed. Most patients in this study 
received a combination of two oral antidiabetic drugs such as metformin 
and acarbose. The two groups were also comparable with respect to 
drug dosage, form, and use of drugs for other conditions. Other drugs 
prescribed in this study population including simvastatin, bisoprolol, 
and valsartan did not affect HbA1c value. The intervention in this study 
for the patients did not improvise patients’ knowledge on the side effect 
of the drugs. There were no correlation intervention group events of 
side effects. Flatulent was the most common side effect in this study 
population [16]. Keban reported that 70% of patients who receive 
acarbose developed diarrhea, nausea, vomiting, and flatulence [17]. 
According to Waspadji, flatulent was found in 50% of α-glycosidase 
inhibitor user [18]. A patient aged 63 years consumed metformin and 
glibenclamide had complaint of shaking and cold sweat which was a 
sign of hypoglycemia. Most likely, the hypoglycemia occurs caused by 
glibenclamide usage.
Correlation with HbA1c level
Type 2 DM patient’s adherence towards HbA1c value after given 
drug information and booklet
At the beginning of the study, the average HbA1c in the intervention 
group was 8.05±0.91%. After receiving drug-related information 
and booklet (week 11), the average HbA1c level in the intervention 
group decreased to 6.92±0.47%, which corresponds to a decrease 
of 1.13±0.62% from the baseline value. In a study by Puspitasari in 
Table 1: Demographic and anthropometric characteristics of patients






Women 13 (86.67) 12 (80)
Men 2 (13.33) 3 (20)
Age (years) 55.73±9.44 59.73±9.47 0.926a
Height (cm) 157.6±7.45 156±7.27 0.557c
Weight (kg) 59.47±8.02 59.47±11.21 1.000c
Body mass index (kg/m2) 23.98±3.09 23.72±4.70 0.856c
Education 0.048a
Low (never attended school) 12 (80) 10 (66.67)
Middle (Middle–Senior high school) 3 (20) 3 (20)
High (University) 0 2 (13.33)
Employment status 0.1000a
Employed 3 (20) 4 (26.67)
Unemployed 12 (80) 11 (73.33)
Data presented as n (%) or average±standard deviation. aPearson’s Chi-square test, bMann–Whitney test, cUnpaired t-test
Fig. 1: Schematic illustration of the study design and 
patient-selection criteria
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Depok, provision of drug information booklet to diabetic patients 
decreased HbA1c value by 1.6±0.55% [8,16]. Another study by 
Keban revealed that provision of counseling by pharmacist may also 
reduce HbA1c value (decrease of 1.76±0.24%) [17]. In the control 
group, the average HbA1c level at baseline was 7.40±0.96% which 
showed a slight increase to 7.50±0.97% at week 11. The between-
group difference with respect to the decrease in HbA1c level was 
statistically significant (paired t-test; p=0.001). The decrease of 
HbA1c value was found 40% in control group and 93.33% in the 
intervention group [19,20]. These findings imply that provision of 
drug-related information and booklet to type 2 DM helped to improve 
patients’ adherence as reflected by the decrease in HbA1c level 
(Figs. 2 and 3, Tables 3-5).
DISCUSSION
This study indicates that pharmacists can play a key role in improving 
treatment compliance among patients with type 2 DM by interventions, 
such as provision of drug information, booklet, and follow-up reminders 
through SMS. Our findings are consistent with those of a study by 
Puspitasari [8]. We believe that providing drug information and patient 
education booklet in this intervention was a complete combination. 
Patient education about diabetes and the treatment has been shown 
to improve glycemic control, reduce the risk of hypoglycemia, and 
reduce treatment cost [21]. Involvement of pharmacists plays a vital 
role in the management of therapy and helps to improve the clinical 
outcomes [22]. Provision information related to drugs and other 






Fasting blood glucose (mg/dL) 174.53 ± 58.94 164.60 ± 48.01 0.561a
2 h postprandial blood glucose (mg/dL) 255.00 ± 89.44 263.53 ± 65.39 0.384a
Blood pressure
Systolic (mmHg) 122.67 ± 11.00 126 ± 6.32 0.432a
Diastolic (mmHg) 77.33 ± 9.61 82.67 ± 5.93 0.129
DM duration (Years) 0.338b
<1 2 (13.33) 4 (26.67)
1–5 8 (53.33) 6 (40)
>5 5 (33.33) 5 (33.33)
Concurrent disease 0.099b
Present 12 (80) 13 (86.67)
Absent 3 (20) 2 (13.33)
Total antidiabetic oral (Types) 0.830b
1 1 (6.67) 1 (6.67)
2 12 (80) 13 (86.67)
3 2 (13.33) 1 (6.67)
Drug usage 0.690b
Appropriate 10 (66.67) 11 (73.33)
Inappropriate 5 (33.33) 4 (26.67)
Other drug prescribed 0.666b
Yes 11 (73.33) 12 (80)
No 4 (26.67) 3 (20)
Side effects 0.690b
Yes 4 (26.67) 5 (33.33)
No 10 (66.67) 9 (60)
Data presented as n (%) or average±standard deviation. aMann–Whitney test, bPearson’s Chi-squared test, DM: Diabetes mellitus
Fig. 2: Pre- and post-intervention hemoglobin A1c level of individual patients in the control group
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aspects of treatment boosts self-efficacy and improves quality of life 
and BMI of diabetic patients [23]. However, the education material 
should be tailored according to the patients’ condition.
Therefore, drug information and booklet are effective interventions to 
increase patient adherence. Suppapitiporn et al. found that pharmacist 
consultation during each visit can increase the effectiveness of blood 
glucose control program [24]. As against random blood glucose 
test, HbA1c levels are not affected by short-term changes in blood 
glucose levels caused by eating, exercise, or intake of medicines. The 
average HbA1c level among patients in Kembangan Health Center 
was categorized as quite good (7.40% and 8.05% in the control and 
intervention groups, respectively). This may reflect the role played 
by the pharmacist at the Kembangan Healthcare Center in West 
Jakarta during the monthly consultation program. However, another 
study should be performed with a larger sample size that represents 
the total population of type 2 DM patients treated at the Kembangan 
Health Center in West Jakarta. Further research should be conducted 
to compare the effectiveness of education media by providing drug 
information and booklet along with other educational media to increase 
patient adherence.
CONCLUSION
A booklet can play a key role in improving treatment compliance 
among patients with type 2 DM. Provision of drug information 
and booklet were found effective in decreasing HbA1c level from 
8.05±0.91 to 6.92±0.47 with delta HbA1c 1.13±0.62 and helped to 
increase the treatment adherence among patients with type 2 DM 
at the Kembangan Health Center, West Jakarta. Therefore, drug 
information and booklet are effective interventions to increase 
patients’ adherence.
Table 3: The average difference between HbA1c levels at week 0 
and week 11 in each study group
Group Average±SD (%) Delta p
Week-0 Week-11
Control (n=15) 7.40±0.96 7.50±0.97 −0.1±0.01 0.653a
Intervention (n=15) 8.05±0.91 6.92±0.47 1.13±0.62 0.000a
SD: Standard deviation aPaired t-test
Fig. 3: Pre- and post-intervention hemoglobin A1c levels of individual patients in the intervention group
Table 4: Average HbA1c level in control group at week 0 and week 11 according to the level of glycemic control
HbA1c level Week 0 Week 11 Delta
Average±SD n (%) Average±SD n (%)
Controlled (≤7) 6.375±0.18 4 (26.66) 6.5±0.36 5 (33.33)




Total 7.49±0.96 15 (100) 7.50±0.97 15 (100) −0.01
HbA1c: Hemoglobin A1c, SD: Standard deviation
Table 5: Average HbA1c level in intervention group at week 0 and week 11 according to the level of glycemic control
HbA1c level Week 0 Week 11 Delta
Average±SD n (%) Average±SD n (%)
Controlled (≤7) 6.63±0.35 3 (20) 6.48±0.26 7 (46.66)




Total 8.05±0.91 6.92±0.47 - 1.13
HbA1c: Hemoglobin A1c, SD: Standard deviation
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